Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 103

1.

Chemotherapy and late course three dimensional conformal radiotherapy for treatment of patients with stage III non- small cell lung cancer.

Liu YC, Zhou SB, Gao F, Ye HX, Zhao Y, Yi XX, Huang XE, Xiang J.

Asian Pac J Cancer Prev. 2013;14(4):2663-5.

2.

Dose-escalation study of three-dimensional conformal thoracic radiotherapy with concurrent S-1 and cisplatin for inoperable stage III non-small-cell lung cancer.

Harada H, Nishio M, Murakami H, Ohyanagi F, Kozuka T, Ishikura S, Naito T, Kaira K, Takahashi T, Horiike A, Nishimura T, Yamamoto N.

Clin Lung Cancer. 2013 Jul;14(4):440-5. doi: 10.1016/j.cllc.2013.01.003. Epub 2013 Mar 27.

PMID:
23540866
3.

[Late course three-dimensional conformal radiotherapy in patients with stage III non-small cell lung cancer].

Wang XC, Wang SY, Yang S, Ding Y, Shang Y.

Di Yi Jun Yi Da Xue Xue Bao. 2005 Jun;25(6):726-8. Chinese.

4.

Randomized phase II trial of induction chemotherapy followed by concurrent chemotherapy and dose-escalated thoracic conformal radiotherapy (74 Gy) in stage III non-small-cell lung cancer: CALGB 30105.

Socinski MA, Blackstock AW, Bogart JA, Wang X, Munley M, Rosenman J, Gu L, Masters GA, Ungaro P, Sleeper A, Green M, Miller AA, Vokes EE.

J Clin Oncol. 2008 May 20;26(15):2457-63. doi: 10.1200/JCO.2007.14.7371.

PMID:
18487565
5.
6.

[Postoperative three-dimensional conformal radiotherapy for resected non-small cell lung cancer].

Ji W, Wang LH, Ou GF, Liang J, Feng QF, Xiao ZF, Chen DF, Lü JM, Zhou ZM, Zhang HX, Yin WB.

Zhonghua Zhong Liu Za Zhi. 2008 Oct;30(10):783-6. Chinese.

PMID:
19173815
7.
8.

Prognosis of non-small cell lung cancer patients with bone oligometastases treated concurrently with thoracic three-dimensional radiotherapy and chemotherapy.

Ouyang WW, Su SF, Ma Z, Hu YX, Lu B, Li QS, Geng YC, Li HQ.

Radiat Oncol. 2014 Jun 24;9:147. doi: 10.1186/1748-717X-9-147.

9.

Results of multifield conformal radiation therapy of nonsmall-cell lung carcinoma using multileaf collimation beams.

Bahri S, Flickinger JC, Kalend AM, Deutsch M, Belani CP, Sciurba FC, Luketich JD, Greenberger JS.

Radiat Oncol Investig. 1999;7(5):297-308.

PMID:
10580899
10.
11.

Phase III study of cisplatin with pemtrexed or vinorelbine plus concurrent late course accelerated hyperfractionated radiotherapy in patients with unresectable stage III non-small cell lung cancer.

Zhao Q, Wang Z, Huang W, Wang Q, Yu S, Zhou T, Han D, Wu Z, Gong H, Sun H, Zhang J, Wei Y, Li H, Zhang Z, Lin H, Li B.

Oncotarget. 2016 Feb 16;7(7):8422-31. doi: 10.18632/oncotarget.6871.

12.

A phase 3 study of induction treatment with concurrent chemoradiotherapy versus chemotherapy before surgery in patients with pathologically confirmed N2 stage IIIA nonsmall cell lung cancer (WJTOG9903).

Katakami N, Tada H, Mitsudomi T, Kudoh S, Senba H, Matsui K, Saka H, Kurata T, Nishimura Y, Fukuoka M.

Cancer. 2012 Dec 15;118(24):6126-35. doi: 10.1002/cncr.26689. Epub 2012 Jun 6.

13.

A Phase I study of chemoradiotherapy with use of involved-field conformal radiotherapy and accelerated hyperfractionation for Stage III non-small cell lung cancer: WJTOG 3305.

Tada T, Chiba Y, Tsujino K, Fukuda H, Nishimura Y, Kokubo M, Negoro S, Kudoh S, Fukuoka M, Nakagawa K, Nakanishi Y.

Int J Radiat Oncol Biol Phys. 2012 May 1;83(1):327-31. doi: 10.1016/j.ijrobp.2011.06.1991. Epub 2011 Nov 11.

PMID:
22079726
14.

[Survival status of stage IV non-small cell lung cancer patients after radiotherapy--a report of 287 cases].

Cai Y, Wang WL, Xu B, Zhu GY, Zhang SW.

Ai Zheng. 2006 Nov;25(11):1419-22. Chinese.

PMID:
17094913
15.
16.

Matched-Pair Analysis of High Dose Versus Standard Dose Definitive Chemoradiation for Locally Advanced Non-Small-Cell Lung Cancer.

Johnson MD, Sura K, Mangona VS, Glick A, Wallace M, Ye H, Grills IS.

Clin Lung Cancer. 2017 Mar;18(2):149-155. doi: 10.1016/j.cllc.2016.06.004. Epub 2016 Jun 23.

PMID:
27426973
17.

A population-based study of primary chemoradiotherapy in clinical stage III non-small cell lung cancer: intensity-modulated radiotherapy versus 3D conformal radiotherapy.

Hsia TC, Tu CY, Chen HJ, Chen SC, Liang JA, Chen CY, Wang YC, Chien CR.

Anticancer Res. 2014 Sep;34(9):5175-80.

PMID:
25202111
18.

Phase I study of concurrent high-dose three-dimensional conformal radiotherapy with chemotherapy using cisplatin and vinorelbine for unresectable stage III non-small-cell lung cancer.

Sekine I, Sumi M, Ito Y, Horinouchi H, Nokihara H, Yamamoto N, Kunitoh H, Ohe Y, Kubota K, Tamura T.

Int J Radiat Oncol Biol Phys. 2012 Feb 1;82(2):953-9. doi: 10.1016/j.ijrobp.2011.01.008. Epub 2011 Mar 4.

PMID:
21377282
19.

Accelerated hypofractionated radiation therapy (AHRT) for non-small-cell lung cancer: can we leave standard fractionation?

de Dios NR, Sanz X, Foro P, Membrive I, Reig A, Ortiz A, Jiménez R, Algara M.

Clin Transl Oncol. 2017 Apr;19(4):440-447. doi: 10.1007/s12094-016-1544-7. Epub 2016 Aug 23.

PMID:
27553602
20.

Proton therapy with concurrent chemotherapy for non-small-cell lung cancer: technique and early results.

Hoppe BS, Flampouri S, Henderson RH, Pham D, Bajwa AA, D'Agostino H, Huh SN, Li Z, Mendenhall NP, Nichols RC.

Clin Lung Cancer. 2012 Sep;13(5):352-8. doi: 10.1016/j.cllc.2011.11.008. Epub 2012 Jan 20.

PMID:
22264659

Supplemental Content

Support Center